Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2016 Filed Apr 5, 2016 23:28 UTC |
Kraft Robert O.EVP and President - Omnicare
|
GrantCommon Stock (restricted) | 3,100 | $104.82 | $324,942.00 |
DisclosureSEC source: 0001127602-16-048903 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,534 F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2010 Incentive Compensation Plan. Restrictions lapse 50% on 4/1/2019 and 50% on 4/1/2021. Read SEC document |
| April 01, 2016 Filed May 27, 2016 20:27 UTC Amendment |
Foulkes HelenaEVP, President-CVS Pharmacy
|
Tax withholdingCommon Stock | 2,199 | $104.82 | $230,499.18 |
DisclosureSEC source: 0001127602-16-053784 · form4a.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS Pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,495.8095 F1 · shares: The purpose of this Amended Form 4/A is to correct the number of surrender of shares in payment of withholding taxes due upon the vesting of restricted stock awards, one of which was deferred, and to correct the resulting share balances in the reporting person's accounts. F2 · balance_after: Corrects the share balance of Common Stock. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 38,247 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,741 Underlying: Common Stock · 38,247 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2011. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 38,247 | $100.00 | $3,824,700.00 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,039.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:05 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 38,247 | $36.23 | $1,385,688.81 |
DisclosureSEC source: 0001127602-16-046101 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 261,286.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2016 Filed Mar 11, 2016 21:08 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 6,755 | $100.00 | $675,500.00 |
DisclosureSEC source: 0001127602-16-046104 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,601.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| March 02, 2016 Filed Mar 3, 2016 21:26 UTC |
BRACKEN RICHARD MDirector
|
GrantCommon Stock | 19 | $98.63 | $1,873.97 |
DisclosureSEC source: 0001127602-16-044827 · form4.xml · nonDerivative · entry 1 BRACKEN RICHARD M · CIK 0001216830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,832 F1 · shares: Consists of common stock issued as the pro rata portion of a committee chair retainer payable for the Reporting Person's service during the 2015-2016 Board year. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:28 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GrantStock Unit | 16,748 | $97.17 | $1,627,403.16 |
DisclosureSEC source: 0001127602-16-044567 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,063.1322 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:31 UTC |
Sussman AndrewEVP & Pres, CVS/minuteclinic
|
GrantStock Unit | 1,675 | $97.17 | $162,759.75 |
DisclosureSEC source: 0001127602-16-044572 · form4.xml · nonDerivative · entry 2 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,114.8918 F2 · shares: Consists of Stock Units awarded at market price to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:31 UTC |
Sussman AndrewEVP & Pres, CVS/minuteclinic
|
GrantCommon Stock | 5,024 | $97.17 | $488,182.08 |
DisclosureSEC source: 0001127602-16-044572 · form4.xml · nonDerivative · entry 1 Sussman Andrew · CIK 0001515706 · EVP & Pres, CVS/minuteclinic 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,885 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:33 UTC |
MERLO LARRY JDirector · President and CEO
|
GrantCommon Stock | 61,412 | $97.17 | $5,967,404.04 |
DisclosureSEC source: 0001127602-16-044574 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,039.8769 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:34 UTC |
Denton David MEVP, CFO
|
GrantCommon Stock | 16,748 | $97.17 | $1,627,403.16 |
DisclosureSEC source: 0001127602-16-044575 · form4.xml · nonDerivative · entry 1 Denton David M · CIK 0001428718 · EVP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,257.1391 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:35 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
GrantCommon Stock | 14,515 | $97.17 | $1,410,422.55 |
DisclosureSEC source: 0001127602-16-044577 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,356.059 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:37 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock | 13,957 | $97.17 | $1,356,201.69 |
DisclosureSEC source: 0001127602-16-044578 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329.3444 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:38 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
GrantCommon Stock | 8,932 | $97.17 | $867,922.44 |
DisclosureSEC source: 0001127602-16-044581 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,109.8095 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:39 UTC |
Bisaccia LisaEVP, Chief HR Officer
|
GrantCommon Stock | 8,932 | $97.17 | $867,922.44 |
DisclosureSEC source: 0001127602-16-044584 · form4.xml · nonDerivative · entry 1 Bisaccia Lisa · CIK 0001479663 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,935 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:41 UTC |
GOLD STEPHEN JEVP & CIO
|
GrantCommon Stock | 7,816 | $97.17 | $759,480.72 |
DisclosureSEC source: 0001127602-16-044587 · form4.xml · nonDerivative · entry 1 GOLD STEPHEN J · CIK 0001252005 · EVP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,126.3558 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:42 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock (restricted) | 1,415 | $97.17 | $137,495.55 |
DisclosureSEC source: 0001127602-16-044588 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,310 F2 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2017. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:42 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
GrantCommon Stock | 2,233 | $97.17 | $216,980.61 |
DisclosureSEC source: 0001127602-16-044588 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,795.4689 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 29, 2016 Filed Mar 2, 2016 22:44 UTC |
Joyner J. DavidEVP, Sales & Account Services
|
GrantCommon Stock | 5,582 | $97.17 | $542,402.94 |
DisclosureSEC source: 0001127602-16-044590 · form4.xml · nonDerivative · entry 1 Joyner J. David · CIK 0001515598 · EVP, Sales & Account Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,757 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan. Read SEC document |
| February 27, 2016 Filed Mar 1, 2016 21:38 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 192 | $97.66 | $18,750.72 |
DisclosureSEC source: 0001127602-16-044157 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,562.4689 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 27, 2016 Filed Mar 1, 2016 21:39 UTC |
Kraft Robert O.EVP and President - Omnicare
|
Tax withholdingCommon Stock | 422 | $97.66 | $41,212.52 |
DisclosureSEC source: 0001127602-16-044159 · form4.xml · nonDerivative · entry 1 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421.8997 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 19, 2016 Filed Feb 22, 2016 21:31 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 463 | $97.59 | $45,184.17 |
DisclosureSEC source: 0001127602-16-042691 · form4.xml · nonDerivative · entry 2 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,178.4689 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 18, 2016 Filed Feb 22, 2016 21:31 UTC |
Boratto Eva CSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock | 346 | $96.89 | $33,523.94 |
DisclosureSEC source: 0001127602-16-042691 · form4.xml · nonDerivative · entry 1 Boratto Eva C · CIK 0001580827 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,262.4689 F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award. Read SEC document |
| February 11, 2016 Filed Feb 11, 2016 22:17 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
SaleCommon Stock | 23,355 | $92.86 | $2,168,745.30 |
DisclosureSEC source: 0001127602-16-040730 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,643.5258 F1 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $92.54 and $93.11 per share. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · derivative · entry 7 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 46,393 | $96.14 | $4,460,009.61 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,627.8769 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $95.58 and $96.73 per share. Read SEC document |
| February 01, 2016 Filed Feb 2, 2016 21:17 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-16-039067 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,020.8769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionStock Option · Derivative | 46,393 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · derivative · entry 4 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,393 Underlying: Common Stock · 46,393 shares Expires 2016-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 4/1/2010. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC |
MERLO LARRY JDirector · President and CEO
|
SaleCommon Stock | 46,393 | $95.00 | $4,407,335.00 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,612.9492 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 11, 2016 Filed Jan 13, 2016 21:16 UTC |
MERLO LARRY JDirector · President and CEO
|
Exercise / conversionCommon Stock | 46,393 | $28.10 | $1,303,643.30 |
DisclosureSEC source: 0001127602-16-036864 · form4.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,005.9492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2016 Filed Jan 5, 2016 22:10 UTC |
Finucane Anne A.Director
|
SaleCommon Stock | 2,000 | $95.87 | $191,749.20 |
DisclosureSEC source: 0001127602-16-035910 · form4.xml · nonDerivative · entry 2 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 14,719 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $95.81 and $96.05 per share. Read SEC document |
| January 02, 2016 Filed Jan 5, 2016 21:57 UTC |
Foulkes HelenaEVP, President-CVS/pharmacy
|
Tax withholdingCommon Stock | 748 | $96.46 | $72,152.08 |
DisclosureSEC source: 0001127602-16-035880 · form4.xml · nonDerivative · entry 1 Foulkes Helena · CIK 0001429996 · EVP, President-CVS/pharmacy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,113.2989 F1 · shares: Surrender of shares in payment of withholding taxes due upon the release of a deferred restricted stock award. Read SEC document |
| November 25, 2015 Filed Jan 5, 2016 22:10 UTC |
Finucane Anne A.Director
|
GiftCommon Stock | 600 | $93.90 | $56,340.00 |
DisclosureSEC source: 0001127602-16-035910 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Finucane Family Trust Disclosed balance after: 16,719 Read SEC document |
| November 12, 2015 Filed Feb 11, 2016 22:17 UTC |
Roberts Jonathan CEVP & President, CVS/caremark
|
GiftCommon Stock | 175 | $93.12 | $16,296.00 |
DisclosureSEC source: 0001127602-16-040730 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & President, CVS/caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,998.5258 Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:02 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,506.4779 | $99.57 Strike: $0.00 | $150,000.00 |
DisclosureSEC source: 0001127602-15-030620 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,832.6407 Underlying: Common Stock · 1,506.4779 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:05 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,406.046 | $99.57 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-15-030624 · form4.xml · derivative · entry 1 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,280.4275 Underlying: Common Stock · 1,406.046 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:07 UTC |
DEPARLE NANCY ANNDirector
|
GrantShare Credits · Derivative | 210.9069 | $99.57 Strike: $0.00 | $21,000.00 |
DisclosureSEC source: 0001127602-15-030628 · form4.xml · derivative · entry 2 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,223.2012 Underlying: Common Stock · 210.9069 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:07 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 843 | $99.57 | $83,937.51 |
DisclosureSEC source: 0001127602-15-030628 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,305 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:10 UTC |
SWIFT RICHARD JDirector
|
GrantShare Credits · Derivative | 1,148.6894 | $99.57 Strike: $0.00 | $114,375.00 |
DisclosureSEC source: 0001127602-15-030631 · form4.xml · derivative · entry 2 SWIFT RICHARD J · CIK 0001200537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,827.3877 Underlying: Common Stock · 1,148.6894 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:12 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,406.046 | $99.57 Strike: $0.00 | $140,000.00 |
DisclosureSEC source: 0001127602-15-030634 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,657.2204 Underlying: Common Stock · 1,406.046 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2010 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:24 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 2,862 | $99.57 | $284,969.34 |
DisclosureSEC source: 0001127602-15-030638 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,469 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:17 UTC |
BRACKEN RICHARD MDirector
|
GrantCommon Stock | 1,054 | $99.57 | $104,946.78 |
DisclosureSEC source: 0001127602-15-030637 · form4.xml · nonDerivative · entry 1 BRACKEN RICHARD M · CIK 0001216830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,813 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:35 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,054 | $99.57 | $104,946.78 |
DisclosureSEC source: 0001127602-15-030647 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,412 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:30 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,054 | $99.57 | $104,946.78 |
DisclosureSEC source: 0001127602-15-030644 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| November 04, 2015 Filed Nov 6, 2015 21:28 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,406 | $99.57 | $139,995.42 |
DisclosureSEC source: 0001127602-15-030641 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 23,603 | $0.00 Strike: $54.53 | $0.00 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,604 Underlying: Common Stock · 23,603 shares Expires 2020-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2014. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
SaleCommon Stock | 23,603 | $105.00 | $2,478,315.00 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,841.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 27, 2015 Filed Oct 28, 2015 20:50 UTC |
Brennan Troyen AEVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 23,603 | $54.53 | $1,287,071.59 |
DisclosureSEC source: 0001127602-15-029685 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,444.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2015 Filed Sep 2, 2015 20:19 UTC |
Kraft Robert O.EVP and President - Omnicare
|
GrantStock Option · Derivative | 55,020 | $102.40 Strike: $102.40 | $5,634,048.00 |
DisclosureSEC source: 0001127602-15-026475 · form4.xml · derivative · entry 4 Kraft Robert O. · CIK 0001558592 · EVP and President - Omnicare 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,020 Underlying: Common Stock · 55,020 shares Expires 2025-08-31 F3 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 8/31/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.